These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3590916)

  • 1. [Repigmentation treatment of vitiligo with L-phenylalanine and UVA irradiation].
    Thiele B; Steigleder GK
    Z Hautkr; 1987 Apr; 62(7):519-23. PubMed ID: 3590916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of vitiligo with phenylalanine and UV-A].
    Rosenbach T; Wellenreuther U; Nürnberger F; Czarnetzki BM
    Hautarzt; 1993 Apr; 44(4):208-9. PubMed ID: 8482598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral phenylalanine loading and sunlight as source of UVA irradiation in vitiligo on the Caribbean island of Curacao NA.
    Kuiters GR; Hup JM; Siddiqui AH; Cormane RH
    J Trop Med Hyg; 1986 Jun; 89(3):149-55. PubMed ID: 3773027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-phenylalanine and UVA irradiation in the treatment of vitiligo.
    Siddiqui AH; Stolk LM; Bhaggoe R; Hu R; Schutgens RB; Westerhof W
    Dermatology; 1994; 188(3):215-8. PubMed ID: 8186511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylalanine plus ultraviolet light: preliminary report of a promising treatment for childhood vitiligo.
    Schulpis CH; Antoniou C; Michas T; Strarigos J
    Pediatr Dermatol; 1989 Dec; 6(4):332-5. PubMed ID: 2616391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenylalanine and UVA light for the treatment of vitiligo.
    Cormane RH; Siddiqui AH; Westerhof W; Schutgens RB
    Arch Dermatol Res; 1985; 277(2):126-30. PubMed ID: 3885873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients.
    Hofer A; Hassan AS; Legat FJ; Kerl H; Wolf P
    Br J Dermatol; 2005 May; 152(5):981-5. PubMed ID: 15888156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case study to evaluate the treatment of vitiligo with khellin encapsulated in L-phenylalanin stabilized phosphatidylcholine liposomes in combination with ultraviolet light therapy.
    de Leeuw J; van der Beek N; Maierhofer G; Neugebauer WD
    Eur J Dermatol; 2003; 13(5):474-7. PubMed ID: 14693493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
    Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
    J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Langerhans' cell population studies with OKT6 and HLA-DR monoclonal antibodies in vitiligo patients treated with oral phenylalanine loading and UVA irradiation.
    Westerhof W; Groot I; Krieg SR; Bos JD; Cormane RH
    Acta Derm Venereol; 1986; 66(3):259-62. PubMed ID: 2426905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects.
    Lotti T; Buggiani G; Troiano M; Assad GB; Delescluse J; De Giorgi V; Hercogova J
    Dermatol Ther; 2008 Jul; 21 Suppl 1():S20-6. PubMed ID: 18727812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repigmentation of vitiligo with punch grafting and narrow-band UV-B (311 nm)--a prospective study.
    Lahiri K; Malakar S; Sarma N; Banerjee U
    Int J Dermatol; 2006 Jun; 45(6):649-55. PubMed ID: 16796620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo.
    Passeron T; Ostovari N; Zakaria W; Fontas E; Larrouy JC; Lacour JP; Ortonne JP
    Arch Dermatol; 2004 Sep; 140(9):1065-9. PubMed ID: 15381545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vitiligo therapy with phenylalanine/UV A. Catamnestic studies after five years].
    Greiner D; Ochsendorf FR; Milbradt R
    Hautarzt; 1994 Jul; 45(7):460-3. PubMed ID: 7928339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo.
    Hartmann A; Lurz C; Hamm H; Bröcker EB; Hofmann UB
    Int J Dermatol; 2005 Sep; 44(9):736-42. PubMed ID: 16135141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of vitiligo using phenylalanine and UVA irradiation].
    Biella U; Haustein UF
    Hautarzt; 1990 Nov; 41(11):636. PubMed ID: 2276919
    [No Abstract]   [Full Text] [Related]  

  • 17. Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study.
    Saraceno R; Nisticò SP; Capriotti E; Chimenti S
    Dermatol Ther; 2009; 22(4):391-4. PubMed ID: 19580584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Narrowband UVB therapy for vitiligo: does the repigmentation last?
    Sitek JC; Loeb M; Ronnevig JR
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):891-6. PubMed ID: 17658996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
    Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
    Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo.
    Arca E; Taştan HB; Erbil AH; Sezer E; Koç E; Kurumlu Z
    J Dermatol; 2006 May; 33(5):338-43. PubMed ID: 16700666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.